 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| MJNA on Two Day Run Up Another 7% on Big Volume Again |
|
 Hot Stock to Watch |
Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)
|
Last:
Price: 0.0588
Change (%): + 0.0041 (7.47)
Volume: 36,956,085 |
 |
Real Scientific Hemp Oil™ Approved for Import Into Brazil for Massive Drug Market: Chronic Pain and Migraine Headache
Many experts and drug industry leaders consider Brazil to be the largest drug market in the world. Not only does Brazil have a large population with more than 200 million people, but the drug consumption rates in this country are quite high. As a result, many drug and pharmaceutical companies have been vying to get approved for the import of their products into Brazil.
Recently, the government of Brazil approved the import of Real Scientific Hemp Oil™ as a medication for chronic pain. RSHO™ is a cannabidiol (CBD) hemp oil product produced by Medical Marijuana, Inc. While chronic pain was the third indication for the import of RSHO™, the first two indications were Parkinson’s disease and epilepsy. Shareholders of Medical Marijuana, Inc. (OTC: MJNA) will be happy to know that many experts report that there is much to look forward to in terms of the market and opportunity for RSHO™ and other CBD hemp oil products in Brazil.
Continue Reading
|
Post-Historic Address With Mexico's President, Activist Raúl Elizalde Meets Medical Marijuana, Inc. CEO, Discusses RSHO-X Federally Approved Import
SAN DIEGO, CA--(Marketwired - May 03, 2016) - After his participation in the Fourth National Debate for the Usage of Marijuana and his historic speech with Mexican President Peña Nieto, Raúl Elizalde, Founder of Por Grace (Por Todos), will hold a meeting with Dr. Stuart Titus, CEO of Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the U.S. Among the meeting discussion topics will be RSHO-X™, the first-ever cannabis product to receive approval from the federal government of Mexico for importation.
Dr. Titus states, "We are extremely impressed with Raul Elizalde's passion for the health and well-being of others around the world. In his speech at the final National Debate on the Usage of Marijuana in Mexico City, he specifically differentiates between the psychoactive forms of cannabis as opposed to non-psychoactive forms -- which includes industrial hemp-derived cannabidiol or 'CBD'. He noted to the audience that there is 'much work to be done' with changing laws about cannabis access in Mexico. However, that work has now received the blessing of Mexico's President Nieto."
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
